PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 15, 2024The Journal of Urology0 citations

Pd19-05 Smarter Screening and Treatment (S3t): Mitigating Harm via Age- & Baseline-Prostate Specific Antigen-Stratified Screening

View Full Paper
JNJames NieNPNynikka R. PalmerRPRena J. Pasick

Key Points

Key points are not available for this paper at this time.

Abstract

You have accessJournal of UrologyProstate Cancer: Detection ii) implementation by primary care providers (PCPs) in an academic health system. METHODS: An evidence-based age & baseline-PSA stratified protocol was developed by a multidisciplinary task force and disseminated to PCPs via continuing medical education. In July 2019, the protocol was implemented as a health maintenance banner in the electronic health record (EHR). EHR data were searched for rates of PSA screening by PCPs in men aged 40-90 by provider and clinic setting from 2015-2021. We examined associations between age and race with receipt of PSA testing over time. Multivariable hierarchical regression was performed to identify testing predictors, with clinic and provider included as nested random effects. RESULTS: Across 18,203 patients, PSA screening increased from 29.1% in 2015 to 39.6% in 2021 (p<0.001) and was noted across all age groups and despite COVID-19. Notably, PSA screening among Black men increased from 29.7% in 2015 to 52.8% in 2021, with younger Black men exhibiting the following gains: 40-44 (4.4% to 7.0%), 45-49 (38.5% to 56.1%), 50-54 (44.7% to 58.6%). In a mixed effects model, Black men were more likely to undergo PSA screening (OR 1.39, 95% CI 1.34-1.44). Screening was less likely in geriatric clinics and there was a wide range in screening (0 to 75%) across individual PCPs in all departments. CONCLUSIONS: Increased PSA screening can be obtained for younger men and Black men following multidisciplinary collaboration, PCP outreach, and an EHR-based intervention. Significant provider variation in screening rates persist, suggesting the need for continued conversation with PCPs. Download PPTDownload PPT Source of Funding: San Francisco Cancer Initiative Prostate Cancer Task Force, UCSF Helen Diller Family Comprehensive Cancer Center © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e441 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information James Nie More articles by this author Nynikka R. Palmer More articles by this author Rena J. Pasick More articles by this author Maria Byron More articles by this author Claire M. de la Calle More articles by this author Samuel L. Washington More articles by this author Coleen Kivlahan More articles by this author Michael B. Potter More articles by this author Matthew Cooperberg More articles by this author Expand All Advertisement PDF downloadLoading ...

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Nie et al. (2024) studied this question.

synapsesocial.com/papers/68e6f2aab6db64358766d75ehttps://doi.org/10.1097/01.ju.0001009448.41537.64.05
Ask AI
Helpful
Bookmark
Share
View Full Paper